TY - JOUR
T1 - Blinding and Sham Control Methods in Trials of Physical, Psychological, and Self- Management Interventions for Pain (Article I)
T2 - a Systematic Review and Description of Methods
AU - Hohenschurz-Schmidt, David
AU - Draper- Rodi, Jerry
AU - Vase, Lene
AU - Scott, Whitney
AU - McGregor, Alison
AU - Soliman, Nadia
AU - MacMillan, Andrew
AU - Olivier, Axel
AU - Cherian, Cybill Ann
AU - Corcoran, Daniel
AU - Abbey, Hilary
AU - Freigang, Sascha
AU - Chan, Jessica
AU - Phalip, Jules
AU - Nørgaard Sørensen, Lea
AU - Delafin, Maite
AU - Cadete Pedro Dos Santos Baptista, Margarida
AU - R Medforth, Naomi
AU - Ruffini, Nuria
AU - Skøtt Andresen, Stephanie Skøtt Andresen
AU - Ytier, Sylvain
AU - Ali, Dorota
AU - Hobday, Harriet
AU - Agung Ngurah Agung Adhiyoga Santosa, Anak
AU - Vollert, Jan
AU - Rice, Andrew SC
N1 - Funding Information:
Mr Hohenschurz-Schmidt reports support through a PhD Studentship from the Alan and Sheila Diamond Trust for this work and personal fees from Altern Health Ltd, outside the submitted work; Dr. Draper-Rodi reports grants from Alan and Sheila Diamond Charitable Trust, during the conduct of the study; Dr. Scott reports grants from Medical Research Council and Versus Arthritis, and from the National Institute for Health and Care Research, outside the submitted work; Dr. Vollert reports personal fees from Vertex Pharmaceuticals and personal fees from Embody Orthopaedic, outside the submitted work; Prof Rice reports personal fees from IMMPACT and grants from the Alan and Sheila Diamond Trust during the conduct of the study, and personal fees from Imperial Consultants, personal fees from MD Anderson Cancer Center, other from spinifex, other from Medicines and Healthcare products Regulatory Agency (MHRA), and Commission on Human Medicines - Neurology, Pain & Psychiatry Expert Advisory Group, all outside the submitted work; In addition, Dr. Rice has a patent WO 2005/079771 & a patent EP13702262.0/ WO2013 110945 pending. All other authors report that they have no conflicts of interest.
Funding Information:
The PhD position supporting this work was funded by the Alan and Sheila Diamond Charitable Trust.
Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/3/1
Y1 - 2023/3/1
N2 - Blinding is challenging in randomised controlled trials of physical, psychological, and self-management therapies for pain, mainly because of their complex and participatory nature. To develop standards for the design, implementation, and reporting of control interventions in efficacy and mechanistic trials, a systematic overview of currently used sham interventions and other blinding methods was required. Twelve databases were searched for placebo or sham-controlled randomised clinical trials of physical, psychological, and self-management treatments in a clinical pain population. Screening and data extraction were performed in duplicate, and trial features, description of control methods, and their similarity to the active intervention under investigation were extracted (protocol registration ID: CRD42020206590). The review included 198 unique control interventions, published between 2008 and December 2021. Most trials studied people with chronic pain, and more than half were manual therapy trials. The described control interventions ranged from clearly modelled based on the active treatment to largely dissimilar control interventions. Similarity between control and active interventions was more frequent for certain aspects (eg, duration and frequency of treatments) than others (eg, physical treatment procedures and patient sensory experiences). We also provide an overview of additional, potentially useful methods to enhance blinding, as well as the reporting of processes involved in developing control interventions. A comprehensive picture of prevalent blinding methods is provided, including a detailed assessment of the resemblance between active and control interventions. These findings can inform future developments of control interventions in efficacy and mechanistic trials and best-practice recommendations.
AB - Blinding is challenging in randomised controlled trials of physical, psychological, and self-management therapies for pain, mainly because of their complex and participatory nature. To develop standards for the design, implementation, and reporting of control interventions in efficacy and mechanistic trials, a systematic overview of currently used sham interventions and other blinding methods was required. Twelve databases were searched for placebo or sham-controlled randomised clinical trials of physical, psychological, and self-management treatments in a clinical pain population. Screening and data extraction were performed in duplicate, and trial features, description of control methods, and their similarity to the active intervention under investigation were extracted (protocol registration ID: CRD42020206590). The review included 198 unique control interventions, published between 2008 and December 2021. Most trials studied people with chronic pain, and more than half were manual therapy trials. The described control interventions ranged from clearly modelled based on the active treatment to largely dissimilar control interventions. Similarity between control and active interventions was more frequent for certain aspects (eg, duration and frequency of treatments) than others (eg, physical treatment procedures and patient sensory experiences). We also provide an overview of additional, potentially useful methods to enhance blinding, as well as the reporting of processes involved in developing control interventions. A comprehensive picture of prevalent blinding methods is provided, including a detailed assessment of the resemblance between active and control interventions. These findings can inform future developments of control interventions in efficacy and mechanistic trials and best-practice recommendations.
UR - http://www.scopus.com/inward/record.url?scp=85147895423&partnerID=8YFLogxK
U2 - 10.1097/j.pain.0000000000002723
DO - 10.1097/j.pain.0000000000002723
M3 - Article
SN - 0304-3959
VL - 164
SP - 469
EP - 484
JO - Pain
JF - Pain
IS - 3
ER -